Nicholas Lysak1, Azra Bihorac, Charles Hobson. 1. aDepartment of Surgery bDepartment of Medicine cDepartment of Health Services Research, Management, and Policy, University of Florida, Gainesville, Florida, USA.
Abstract
PURPOSE OF REVIEW: Acute and chronic kidney diseases (AKI and CKD) have far-reaching implications for surgical patients in regards to postoperative outcomes and hospital cost. We review the recent literature on the effects of AKI and CKD on morbidity, mortality, and resource utilization among cardiac surgery patients. RECENT FINDINGS: Both AKI and CKD increase the risk for short-term and long-term mortalities, morbidity, length of stay, and hospital cost among postoperative patients, with increasing disease stage correlating with worse outcomes. Even the mildest forms of AKI (RIFLE-R) and CKD (proteinuria without an observed reduction in estimated glomerular filtration rate) demonstrate worse clinical outcomes compared with patients with no AKI or CKD. Outcomes are worse even in patients who achieve full renal recovery before hospital discharge. These complications dramatically increase ICU length of stay, hospital length of stay, resource utilization, and both in-hospital and postdischarge costs, as evidenced by lower rates of discharges to home. SUMMARY: AKI and CKD remain prevalent, morbid, and costly conditions for cardiac surgery patients. Better risk stratification, early diagnosis, and earlier interventions are needed to prevent the consequences of these diseases.
PURPOSE OF REVIEW: Acute and chronic kidney diseases (AKI and CKD) have far-reaching implications for surgical patients in regards to postoperative outcomes and hospital cost. We review the recent literature on the effects of AKI and CKD on morbidity, mortality, and resource utilization among cardiac surgery patients. RECENT FINDINGS: Both AKI and CKD increase the risk for short-term and long-term mortalities, morbidity, length of stay, and hospital cost among postoperative patients, with increasing disease stage correlating with worse outcomes. Even the mildest forms of AKI (RIFLE-R) and CKD (proteinuria without an observed reduction in estimated glomerular filtration rate) demonstrate worse clinical outcomes compared with patients with no AKI or CKD. Outcomes are worse even in patients who achieve full renal recovery before hospital discharge. These complications dramatically increase ICU length of stay, hospital length of stay, resource utilization, and both in-hospital and postdischarge costs, as evidenced by lower rates of discharges to home. SUMMARY: AKI and CKD remain prevalent, morbid, and costly conditions for cardiac surgery patients. Better risk stratification, early diagnosis, and earlier interventions are needed to prevent the consequences of these diseases.
Authors: Madhav Swaminathan; Christopher C C Hudson; Barbara G Phillips-Bute; Uptal D Patel; Joseph P Mathew; Mark F Newman; Carmelo A Milano; Andrew D Shaw; Mark Stafford-Smith Journal: Ann Thorac Surg Date: 2010-04 Impact factor: 4.330
Authors: Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates Journal: J Am Soc Nephrol Date: 2005-09-21 Impact factor: 10.121
Authors: Azra Bihorac; Sinan Yavas; Sophie Subbiah; Charles E Hobson; Jesse D Schold; Andrea Gabrielli; A Joseph Layon; Mark S Segal Journal: Ann Surg Date: 2009-05 Impact factor: 12.969
Authors: George J Arnaoutakis; Azra Bihorac; Tomas D Martin; Philip J Hess; Charles T Klodell; A Ahsan Ejaz; Cyndi Garvan; Curtis G Tribble; Thomas M Beaver Journal: J Thorac Cardiovasc Surg Date: 2007-10-29 Impact factor: 5.209
Authors: Andrea Lassnigg; Daniel Schmidlin; Mohamed Mouhieddine; Lucas M Bachmann; Wilfred Druml; Peter Bauer; Michael Hiesmayr Journal: J Am Soc Nephrol Date: 2004-06 Impact factor: 10.121
Authors: R Bellomo; S Auriemma; A Fabbri; A D'Onofrio; N Katz; P A McCullough; Z Ricci; A Shaw; C Ronco Journal: Int J Artif Organs Date: 2008-02 Impact factor: 1.595
Authors: Lasith Adhikari; Tezcan Ozrazgat-Baslanti; Matthew Ruppert; R W M A Madushani; Srajan Paliwal; Haleh Hashemighouchani; Feng Zheng; Ming Tao; Juliano M Lopes; Xiaolin Li; Parisa Rashidi; Azra Bihorac Journal: PLoS One Date: 2019-04-04 Impact factor: 3.240
Authors: William H Shuman; Sean N Neifert; Jonathan S Gal; Daniel J Snyder; Brian C Deutsch; Jeffrey H Zimering; Robert J Rothrock; John M Caridi Journal: Global Spine J Date: 2020-10-09